ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $317,000 | +49.5% | 25,805 | +2.0% | 0.00% | +100.0% |
| Q2 2017 | $212,000 | -4.9% | 25,305 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $223,000 | -13.2% | 24,985 | -14.4% | 0.00% | -50.0% |
| Q4 2016 | $257,000 | +32.5% | 29,185 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $194,000 | +94.0% | 28,785 | +2.7% | 0.00% | +100.0% |
| Q2 2016 | $100,000 | +20.5% | 28,035 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $83,000 | -29.7% | 28,035 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $118,000 | -13.9% | 27,980 | -6.7% | 0.00% | 0.0% |
| Q3 2015 | $137,000 | -36.0% | 29,980 | +1.1% | 0.00% | -50.0% |
| Q2 2015 | $214,000 | +9.2% | 29,640 | +11.3% | 0.00% | 0.0% |
| Q1 2015 | $196,000 | +55.6% | 26,640 | +0.3% | 0.00% | +100.0% |
| Q4 2014 | $126,000 | +27.3% | 26,550 | -4.7% | 0.00% | 0.0% |
| Q3 2014 | $99,000 | +106.2% | 27,850 | +164.0% | 0.00% | 0.0% |
| Q2 2014 | $48,000 | – | 10,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |